Indian Drug Firms Realign Marketing Structures For More Profitability And Cost Savings
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Impending risk from loss of market share and fewer products in their pipelines are pushing small and medium-sized Indian drug makers to restructure their marketing operations